ABL Bio Inc. (KOSDAQ: 298380)

South Korea flag South Korea · Delayed Price · Currency is KRW
28,150
-650 (-2.26%)
Sep 11, 2024, 11:58 AM KST
42.46%
Market Cap 1.34T
Revenue (ttm) 32.95B
Net Income (ttm) -40.00B
Shares Out 48.05M
EPS (ttm) -835.70
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 524,041
Open 28,850
Previous Close 28,800
Day's Range 28,100 - 29,450
52-Week Range 15,370 - 38,500
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 8, 2024

About ABL Bio

ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio Inc.is headquartered in Seongnam-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
CEO Sang Hoon Lee
Employees 102
Stock Exchange KOSDAQ
Ticker Symbol 298380
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.